Forma Therapeutics, Inc.: Series B $25.5M

Posted in I - Series B, Q - 4Q09, R - NORTH EAST, X - Computational Discovery, X - Device (HTS), XX - MA

Forma Therapeutics (Cambridge, MA) a development-stage screening and discovery company focused on cancer therapies, closed a $25.5M Series B financing. Participants include Lilly Ventures, Novartis Option Fund and Bio*One Capital.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Feb

2010

Therasis, Inc.: Series A $12M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Computational Discovery, X - Device (HTS), XX - NY

Therasis (New York, NY) a development-stage computational systems biology cancer HTS drug discovery platform, closed a $12M Series A financing. Participants include Tilocor Life Science.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Jan

2010

Ligon Discovery, Inc.: Series A $1M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Device (HTS), X - Device (Microarray), XX - MA

Ligon Discovery (Cambridge, MA) a development-stage HTS drug-discovery platform employing Small Molecule Microarray technology, closed a $1M seed financing. Participants include incTank Ventures.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

to top of page...